Cite

HARVARD Citation

    Snook, A. et al. (2015). A Phase I study of AD5-GUCY2C-PADRE in stage I and II colon cancer patients. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online]. 
  
Back to record